Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1991-4-17
pubmed:abstractText
The synthesis of a novel series of smooth muscle relaxants which have been shown to act via the opening or activation of potassium channels is described. Compounds have been evaluated for their ability to inhibit spontaneous tone in guinea pig isolated trachealis and structure-activity relationships are discussed. One compound in particular, 1,1-dimethyl-5-nitro-3-(2-pyridon-1-yl)indan-2-ol, (16) was identified as a potent relaxant of airways smooth muscle in vitro with IC50 = 0.15 microM and was found to significantly inhibit histamine-induced dyspnoea in conscious guinea pigs when given orally 30-45 min prior to challenge.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
919-26
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:2002472-Amides, pubmed-meshheading:2002472-Animals, pubmed-meshheading:2002472-Benzopyrans, pubmed-meshheading:2002472-Bronchi, pubmed-meshheading:2002472-Bronchodilator Agents, pubmed-meshheading:2002472-Chemical Phenomena, pubmed-meshheading:2002472-Chemistry, pubmed-meshheading:2002472-Cromakalim, pubmed-meshheading:2002472-Guinea Pigs, pubmed-meshheading:2002472-Indans, pubmed-meshheading:2002472-Male, pubmed-meshheading:2002472-Molecular Structure, pubmed-meshheading:2002472-Muscle, Smooth, pubmed-meshheading:2002472-Muscle Relaxation, pubmed-meshheading:2002472-Parasympatholytics, pubmed-meshheading:2002472-Potassium Channels, pubmed-meshheading:2002472-Pyrroles, pubmed-meshheading:2002472-Stereoisomerism, pubmed-meshheading:2002472-Structure-Activity Relationship, pubmed-meshheading:2002472-Trachea
pubmed:year
1991
pubmed:articleTitle
Synthesis and smooth muscle relaxant activity of a new series of potassium channel activators: 3-amido-1,1-dimethylindan-2-ols.
pubmed:affiliation
SmithKline Beecham Pharmaceuticals, Biosciences Research Centre, Epsom, Surrey, England.
pubmed:publicationType
Journal Article